Dr Richard Arnold Leone, MD in Allegany, NY - Dermatology

Dr Richard Arnold Leone, MD is a Dermatology physician based in Allegany, New York. Dr Richard Arnold Leone is licensed to practice in New York (license number 091050) and his current practice location is 12 Sunburst Ln, Allegany, New York. He can be reached at his office (for appointments etc.) via phone at (716) 373-2827.

NPI number for Dr Richard Arnold Leone is 1558591909 and his current mailing address is 12 Sunburst Ln, Allegany, New York. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1558591909.

Contact Information

	Dr Richard Arnold Leone, MD
	12 Sunburst Ln, Allegany, NY 14706-9695
	(716) 373-2827
	Not Available

Physician's Profile

Full Name	Dr Richard Arnold Leone
Gender	Male
Speciality	Dermatology
Location	12 Sunburst Ln, Allegany, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1558591909
Provider Enumeration Date: 07/20/2009
Last Update Date: 07/20/2009

Medical Identifiers

Medical identifiers for Dr Richard Arnold Leone such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1558591909	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	091050 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Richard Arnold Leone is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Richard Arnold Leone, MD 12 Sunburst Ln, Allegany, NY 14706-9695 Ph: (716) 373-2827	Dr Richard Arnold Leone, MD 12 Sunburst Ln, Allegany, NY 14706-9695 Ph: (716) 373-2827

News Archive

Study identifies potential new approaches to curing parasitic diseases

A study in the Proceedings of the National Academy of Sciences shows that some forms of the single celled parasites, Trypanosoma brucei and Toxoplasma gondii behave like cancer cells.

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Pfizer Inc. announced today top-line results from two pivotal Phase 3 trials from the Oral treatment Psoriasis Trials (OPT) Program, OPT Pivotal #1 (A3921078) and OPT Pivotal #2 (A3921079), evaluating the efficacy and safety of tofacitinib, an oral Janus kinase (JAK) inhibitor, the first in a new class of medicines being investigated for the treatment of moderate-to-severe plaque psoriasis.

Biochemical link between misery and death discovered

In ongoing work to identify how genes interact with social environments to impact human health, UCLA researchers have discovered what they describe as a biochemical link between misery and death. In addition, they found a specific genetic variation in some individuals that seems to disconnect that link, rendering them more biologically resilient in the face of adversity.

New clinical trial of MS drug will be first to recognize needs of wheelchair users

A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.

Dr Richard Arnold Leone, MD - Dermatology in Allegany, NY